Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014

Cefepime-tazobactam (WCK 4282) is currently under clinical development for use at a dosage of 2 g/2 g every 8 h. A total of 7,981 isolates were collected from 146 medical centers (39 countries) in 2014 as a part of the SENTRY Antimicrobial Surveillance Program, and their susceptibilities to cefepime...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Sader, Helio S., Castanheira, Mariana, Mendes, Rodrigo E., Flamm, Robert K., Jones, Ronald N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2017
Konular:
Epidemiology and Surveillance
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5365660/
https://ncbi.nlm.nih.gov/pubmed/28137811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02409-16
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller